Study | Type of prophylaxis | Rifaximin dose | Norfloxacin dose | Follow-up period |
---|---|---|---|---|
Mostafa et al14 | Secondary | 800 mg daily | 400 mg daily | 6 month |
Shamseya and Madkour15 | Both primary and secondary | 1200 mg daily | 400 mg daily | 1 year |
Assem et al16 | Primary | 1100 mg daily | 400 mg daily | 6 month |
Elfert et al17 | Secondary | 1200 mg daily | 400 mg daily | 6 month |